Home World News Nivolumab Plus AVD Prolongs PFS in Adolescents and Adults with Advanced-Stage Classic... World News Nivolumab Plus AVD Prolongs PFS in Adolescents and Adults with Advanced-Stage Classic Hodgkin’s Lymphoma By Ogkologos - October 30, 2024 3219 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the S1826 study Source RELATED ARTICLESMORE FROM AUTHOR New on NCI’s Websites for November 2024 A Short-Course of Induction Chemotherapy Followed by Chemoradiotherapy Significantly Improves Survival in Patients with Locally Advanced Cervical Cancer Targeted Therapy, Driven by Comprehensive Genomic Profiling and Molecular Tumour Board, Improves Outcomes In Pretreated Patients with Metastatic Cancer MOST POPULAR Study Clarifies Timing of Immunotherapy for Advanced Bladder Cancer June 24, 2020 Our COVID-19 Response: How We’re Supporting Frontline Workers At Revolution Foods April 27, 2020 Working to Address Inequities in Cancer Care: 2021 ASCO Annual Meeting... July 8, 2021 Cooperativity of BRAF/MAPK Pathway Inhibition and Immune Checkpoint Blockade in Patients... February 3, 2023 Load more HOT NEWS Capmatinib Shows Activity in Advanced NSCLC with a MET Exon 14... What to Know About Getting Access to New Cancer Advances Presented... The rise of the ‘long-waiter’ – why cancer waiting times are... Can we grow the treatments of tomorrow? – That Cancer Conversation
